You usually only need to inhale when you are stuffy. Unless your doctor has advised you on a schedule. If you have forgotten an inhalation in that case, you can still take it. Make sure you use the next inhalation for at least four hours after this.
What is Ventolin hfa inhaler?
Ventolin hfa inhaler is a selective ß2-adrenergic receptor agonist, a short-acting bronchodilator, which belongs to the group of medicines called sympathomimetics. The active substance in Ventolin hfa inhaler is salbutamol. Ventolin hfa inhaler relaxes the muscles in the walls of the small airway passages in the lungs in asthma, chronic bronchitis and emphysema. This makes the small airways wider and air easier to enter and exit the lungs.
Who is Ventolin hfa inhaler for?
The indications for Ventolin hfa inhaler are:
- The treatment of acute and intermittent attacks of reversible airway obstruction in bronchial, chronic bronchitis and emphysema.
- Increasing use of short-acting ß2 sympathomimetics may indicate worsening of asthma. Under these circumstances, it may be necessary to adjust the treatment schedule of the patient. Concomitant treatment with corticosteroids should be considered.
The dose or frequency of administration should only be increased on medical advice.
For dosages, route of administration and side effects you can consult the package leaflets.
Non-pharmacological recommendations for asthma include smoking cessation, adequate exercise, avoidance of stimuli and weight reduction in obesity. For less frequent asthma complaints (≤ 2 × / week), the use of a short-acting 2 sympathomimetic (such as salbutamol) is recommended if necessary. For more frequent complaints (≥ 3 × / week) and more frequent use of a short-acting 2 sympathomimetic, maintenance treatment with an inhaled corticosteroid (ICS) is indicated. If insufficient asthma control is achieved, a long-acting 2 sympathomimetic can be added to the maintenance treatment with ICS.
A short-acting 2 sympathomimetic is given for a non-severe exacerbation of asthma. In adults, a temporary increase in inhaled corticosteroids may also be considered in the case of a non-severe exacerbation. In case of severe exacerbation of asthma, salbutamol and possibly ipratropium (via dose aerosol or nebulisation) is given. A course with an oral corticosteroid (prednisolone) is also given. In patients with severe dyspnoea and swallowing problems, one-time dexamethasone can be administered i.m.
In COPD, the most important steps in treatment are: stopping smoking and exercising adequately. Initially (with a slight disease burden) start with a short-acting bronchodilator: ipratropium or a 2-sympathomimetic (such as salbutamol). In case of persistent complaints and / or exacerbations, maintenance treatment with a long-acting bronchodilator (parasympatholytic, 2-sympathomimetic) is indicated. In case of frequent severe exacerbations (≥ 2 treatments / year or ≥ 1 hospitalization / year), a test treatment with inhaled corticosteroids can be started in addition to the long-acting bronchodilator. When choosing an inhaler, patient-related factors, such as coordination and inspirational power, play an important role in achieving an optimal effect.
In case of a non-severe exacerbation of COPD, an oral corticosteroid (prednisolone) is given in case of insufficient effect of bronchodilators in maximum doses. In case of severe exacerbation of COPD, salbutamol and possibly ipratropium (via dosa-aerosol or nebulisation) are given. A course with an oral corticosteroid (prednisolone) is also given. In patients with severe dyspnoea and swallowing problems, one-time dexamethasone can be administered i.m.
For an optimal effect of drugs in asthma and chronic obstructive pulmonary disease (COPD), proper inhalation technique is indispensable. When choosing an inhaler, the patient’s preference plays an important role. Powder inhalers are preferred in adults and children over 7 years of age. They are just as effective as dosaerosols and give less cause to an incorrect implementation of the inhalation. For children up to 7 years and patients with low inspirational power (eg COPD), a dose inhaler with inhalation chamber (eg ‘Babyhaler’, ‘Volumatic’) is still required.